BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

A new research paper was published in Oncotarget, entitled, “Plasma levels of BCMA-positive extracellular vesicles correlate to response and side effects in myeloma patients treated with belantamab-mafodotin.”

Leave A Comment

Your email address will not be published. Required fields are marked *